First District Congressman Mike Flood recently addressed constituents in Norfolk, Nebraska, where medical cannabis enforcement and federal rescheduling were prominent topics. The town hall, held on Tuesday, saw Flood fielding questions on various policy matters, including the state’s approach to medical cannabis implementation amidst strong voter support.
Medical Cannabis Enforcement and Federal Stance
During the town hall, constituents pressed Congressman Flood on the slow progress of a medical marijuana commission under Governor Jim Pillen, despite Nebraska voters having overwhelmingly supported medical cannabis initiatives. Flood reiterated his opposition to medical cannabis, citing concerns about its effects on public health and the economy. He stated, “When I talk to people on the East and West Coast, they tell me it’s the worst thing they’ve ever seen happen in their home state,” according to Nebraska Public Media.
Flood acknowledged the will of the voters, stating that to “breed respect” for elections, state lawmakers should carry out voter-approved measures without undue delay, even if he personally disagrees. However, when asked by Crista Eggers, executive director of Nebraskans for Medical Marijuana, about his continued opposition to federal rescheduling of cannabis, Flood clarified his position:
- He will take no action at the state level regarding medical cannabis, as it is the “law of the land in the state of Nebraska.”
- He will not use his advocacy efforts to support the reclassification of cannabis at the federal level.
This stance indicates a separation between state-level implementation, which he believes should proceed per voter will, and federal policy, where he maintains his opposition to reclassification.
Legislative Context and Public Sentiment
The discussion around medical cannabis at the town hall reflects ongoing challenges in Nebraska regarding patient access and program implementation. As previously reported by Hemp Gazette, Nebraskans for Medical Marijuana has conducted statewide town halls to address these issues, highlighting the public’s desire for a functional medical cannabis program. The state has been described by Flood as the “wild west” due to legislative indecisiveness over the years, contributing to the current implementation delays.
Other Policy Discussions
Beyond medical cannabis, Congressman Flood addressed several other policy and economic issues:
- Housing Legislation: Flood highlighted his recently passed bill, the 21st Century ROAD to Housing Act, aimed at expanding affordable housing in rural Nebraska. He stated the bill reduces the cost of manufactured homes by up to 30%, saving buyers at least US$25,000, by reducing compliance issues for builders using federal funds. The bill reportedly passed the House with 396 votes, including every present House Democrat.
- Federal Spending: Attendees raised concerns about federal spending. Flood referenced a “One Big Beautiful Bill” that he stated cut federal spending by over US$1.5 trillion, affecting programs such as SNAP, Pell grants, and healthcare.
- Economic Affordability: Discussions included high prices for gas, groceries, and farming supplies, which Flood attributed partly to international conflicts. He maintained that his work on housing would contribute to overall affordability.
Congressman Flood plans to hold two additional town halls in his district’s metropolitan areas, with dates yet to be determined, continuing to engage with constituents on these and other policy matters.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
